Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PanOxyl is a leading consumer healthcare brand specializing in over-the-counter dermatological treatments, primarily known for its high-strength benzoyl peroxide acne washes. Originally developed by Stiefel Laboratories, the brand was acquired by GSK and subsequently purchased by Crown Laboratories in 2018. PanOxyl's product portfolio includes a variety of acne management solutions such as foaming washes, spot treatments, and clarifying patches. The brand is widely recommended by dermatologists for its efficacy in treating inflammatory acne by eliminating acne-causing bacteria and clearing pores. PanOxyl continues to operate as a core brand within Crown Laboratories' consumer division, maintaining its position as the top-selling acne wash brand in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PanOxyl.